Paolo Verdecchia
Paolo Verdecchia
Presidente Fondazione Umbra Cuore e Ipertensione-ONLUS
No verified email
TitleCited byYear
Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ...
Circulation 127 (1), 143-152, 2013
Heart disease and stroke statistics-2016 update a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 133 (4), e38-e48, 2016
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.
P Verdecchia, C Porcellati, G Schillaci, C Borgioni, A Ciucci, M Battistelli, ...
Hypertension 24 (6), 793-801, 1994
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
E O'brien, R Asmar, L Beilin, Y Imai, JM Mallion, G Mancia, T Mengden, ...
Journal of hypertension 21 (5), 821-848, 2003
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.
P Verdecchia, G Schillaci, M Guerrieri, C Gatteschi, G Benemio, F Boldrini, ...
Circulation 81 (2), 528-536, 1990
American Heart Association statistics committee and stroke statistics subcommittee
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
Prognostic significance of endothelial dysfunction in hypertensive patients
F Perticone, R Ceravolo, A Pujia, G Ventura, S Iacopino, A Scozzafava, ...
Circulation 104 (2), 191-196, 2001
European Society of Hypertension position paper on ambulatory blood pressure monitoring
E O’Brien, G Parati, G Stergiou, R Asmar, L Beilin, G Bilo, D Clement, ...
Journal of hypertension 31 (9), 1731-1768, 2013
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement
E O'Brien, R Asmar, L Beilin, Y Imai, G Mancia, T Mengden, M Myers, ...
Journal of hypertension 23 (4), 697-701, 2005
Prognostic significance of serial changes in left ventricular mass in essential hypertension
P Verdecchia, G Schillaci, C Borgioni, A Ciucci, R Gattobigio, I Zampi, ...
Circulation 97 (1), 48-54, 1998
Prognostic value of ambulatory blood pressure: current evidence and clinical implications
P Verdecchia
Hypertension 35 (3), 844-851, 2000
Statistical guidelines for contributors to medical journals.
DG Altman, SM Gore, MJ Gardner, SJ Pocock
British medical journal (Clinical research ed.) 286 (6376), 1489, 1983
Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study
P Verdecchia, G Schillaci, GP Reboldi, F Santeusanio, C Porcellati, ...
Hypertension 36 (6), 1072-1078, 2000
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
European Atrial Fibrillation Trial Study Group
Lancet 342 (8882), 1255-62, 1993
Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension
G Schillaci, P Verdecchia, C Porcellati, O Cuccurullo, C Cosco, ...
Hypertension 35 (2), 580-586, 2000
Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension
P Verdecchia, G Schillaci, C Borgioni, A Ciucci, S Pede, C Porcellati
Hypertension 32 (6), 983-988, 1998
Adverse prognostic significance of new diabetes in treated hypertensive subjects
P Verdecchia, G Reboldi, F Angeli, C Borgioni, R Gattobigio, L Filippucci, ...
Hypertension 43 (5), 963-969, 2004
Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass
P Verdecchia, G Schillaci, C Borgioni, A Ciucci, M Battistelli, C Bartoccini, ...
Journal of the American College of Cardiology 25 (4), 871-878, 1995
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention
P Verdecchia, G Reboldi, F Angeli, R Gattobigio, M Bentivoglio, L Thijs, ...
Hypertension 46 (2), 386-392, 2005
The system can't perform the operation now. Try again later.
Articles 1–20